About NovaLign Orthopaedics
NovaLign Orthopaedics is a company based in Memphis (United States) founded in 2005 was acquired by Sonoma Orthopedics in February 2011. NovaLign Orthopaedics has raised $10 million across 1 funding round from investors including Sonoma Orthopedics, Versant Ventures and Accuitive Medical Ventures. NovaLign Orthopaedics operates in a competitive market with competitors including Biomet, Treace Medical Concepts, Bioretec, IlluminOss Medical and Loci Orthopaedics, among others.
- Headquarter Memphis, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series B
Jul 01, 2007
-
Investors
Sonoma Orthopedics
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Sonoma Orthopedics
(Feb 11, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NovaLign Orthopaedics
NovaLign Orthopaedics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series B round of $10 million completed in July 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $10.0M
-
First Round
First Round
(01 Jul 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2007 | Amount | Series B - NovaLign Orthopaedics | Valuation |
investors |
Investors in NovaLign Orthopaedics
NovaLign Orthopaedics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Sonoma Orthopedics, Versant Ventures and Accuitive Medical Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location |
Investments & Acquisitions by NovaLign Orthopaedics
Financial Statements - NovaLign Orthopaedics
Novalign Orthopaedics Comparisons
Competitors of NovaLign Orthopaedics
NovaLign Orthopaedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomet, Treace Medical Concepts, Bioretec, IlluminOss Medical and Loci Orthopaedics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Orthopedic surgical and non-surgical products are designed and distributed.
|
|
| domain | founded_year | HQ Location |
Orthopedic foot and ankle correction systems are developed and offered.
|
|
| domain | founded_year | HQ Location |
Provider of bioabsorbable, bioactive and drug-releasing surgical implants
|
|
| domain | founded_year | HQ Location |
Minimally invasive orthopedic systems for bone fracture stabilization are developed.
|
|
| domain | founded_year | HQ Location |
Thumb implant for thumb base arthritis
|
|
| domain | founded_year | HQ Location |
Orthopedic medical devices for upper and lower extremities are developed.
|
Latest news on Novalign Orthopaedics
Frequently Asked Questions about NovaLign Orthopaedics
NovaLign Orthopaedics was founded in 2005 and raised its 1st funding round 2 years after it was founded.
NovaLign Orthopaedics is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
Jeff Roberts is the current CEO of NovaLign Orthopaedics.
NovaLign Orthopaedics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series B of $10M, raised on Jul 01, 2007.
NovaLign Orthopaedics(known as OsteoLign till 2009) develops minimally invasive products for treating long bone fractures like those of bones in the thigh, shin, and calf. It makes Intramedullary fixation system, an FDA cleared system of implants and instruments for humerus, tibia, and femoral fractures that allow less invasive fixation without affecting surrounding joints; and Extra-capsular intramedullary device that allows a surgeon to repair a long bone fracture. Novalign was acquired by Sonoma Orthopaedics in 2011.
NovaLign Orthopaedics's top competitors include Treace Medical Concepts, Loci Orthopaedics and Bioretec.
NovaLign Orthopaedics has 4 investors. Key investors include Sonoma Orthopedics, Versant Ventures, Accuitive Medical Ventures, and SV Health Investors.